Introduction
Apoptosis is a fundamental physiological process that plays a crucial role in the development and maintenance of homeostasis in multicellular organisms. The balance between the life and death of cells is governed by multiple regulators that either promote survival or are responsible for initiating and executing cell death.
Recent evidence indicates that the mitochondria function as a pivotal control point where dierent apoptotic signals converge (reviewed in Adams and Cory, 1998; Green and Reed, 1998; Tsujimoto and Shimizu, 2000) . Mitochondria are capable of releasing apoptogenic factors. including cytochrome c and apoptosis-inducing factor (AIF), into the cytoplasm.
Once in the cytoplasm, cytochrome c activates caspase-9, an apical caspase with the help of Apaf-1 and deoxyATP (or ATP), and subsequently caspase-9, activates caspase-3, an eector caspase (Li et al., 1997: reviewed by Thornberry and Lazebnik, 1998) . AIF has been reported to induce apoptotic nuclear changes in a caspase-independent manner (Susin et al., 1999) . It has also been shown that Bcl-2 family proteins regulate apoptotic mitochondrial changes: pro-apoptotic Bax and Bak induce cytochrome c release and Dc loss, while anti-apoptotic Bcl-2 and Bcl-x L prevent these changes in cells as well as in isolated mitochondria (Jurgensmeier et al., 1998 : Narita et al., 1998 : Marzo et al., 1998 : Eskes et al., 1998 : Finucane et al., 1999 . We and others have shown that Bax-and Bakinduced cytochrome c release and Dc loss are regulated by a polyprotein channel called the permeability transition (PT) pore (Narita et al., 1998 : Marzo et al., 1998 . This pore is considered to consist of the mitochondrial voltagedependent anion channel (VDAC, also called porin), the adenine nucleotide translocator (ANT), cyclophilin D, and some other molecules (reviewed in Bernardi et al., 1994: Zoratti and SzaboÂ , 1995) . The VDAC has also recently been shown to be one of the functional targets for Bcl-family proteins (Shimizu et al., 1999 (Shimizu et al., , 2000a Shimizu and Tsujimoto, 2000) : Bax/Bak opens the VDAC on liposomes so that cytochrome c passes through the channel, whereas Bcl-x L closes the VDAC via direct binding. An essential role of the VDAC in Bax/Bak-mediated cytochrome c and loss of mitochondrial membrane potential (Dc) was con®rmed by the observation that Bax/Bak induces cytochrome c release and Dc loss in wild-type but not VDAC-1-de®cient yeast mitochondria (Shimizu et al., 1999) .
Gelsolin is an actin-regulatory protein, that participates in the regulation of cell motility and morphogenesis (Yin and Stossel, 1979; Cunningham et al., 1998) . Gelsolin contains six homologous domains (G1 ± 6), each of which has a discrete function (Kwiatkowski et al., 1986; Vandekerckhove, 1990; Ohtsu et al., 1997) . Namely, G1 binds to actin monomers in a Ca 2+ -independent manner, and the complex is capable of capping actin fragments. G2 contains a Ca 2+ -independent actin polymer binding site and is capable of binding to actin ®laments. The N-terminal fragment with G1 ± 3 carries F-actin-cutting activity, and the Cterminal fragment with G4 ± 6 carries a Ca 2+ -dependent actin monomer binding activity. Recent studies have suggested an important role of gelsolin in apoptosis signal transduction: (1) overexpression of human gelsolin (hGsn) in Jurkat cells inhibits apoptosis by blocking cytochrome c release and thereby inhibiting caspase activation (Ohtsu et al., 1997; Kamada et al., 1998) ; (2) hGsn and mouse gelsolin (mGsn) are cleaved at a site within the G3 domain by caspases during apoptosis (Kothakota et al., 1997; Kamada et al., 1998) ; (3) the cleaved mouse N-terminal fragment cuts actin ®laments in a Ca 2+ -independent manner and induces apoptosis (Kothakota et al., 1997) ; (4) neutrophils and neurons from gelsolin-de®cient mice show resistance and enhanced susceptibility to apoptosis, respectively (Kothakota et al., 1997; Endres et al., 1999) ; (5) Gsn in complex with phosphatidylinositol 4,5-bisphosphate inhibits caspases (Azuma et al., 2000) . More recently, Koya et al. in collaboration with us found that recombinant hGsn could prevent apoptotic mitochondrial changes in isolated mitochondria (Koya et al., 2000) . Here we extended that study, and found that hGsn, but not mGsn, inhibits apoptosis by preventing apoptotic mitochondrial changes and that, like anti-apoptotic Bcl-x L , hGsn can inhibit VDAC activity on liposomes, thereby preventing apoptotic mitochondrial changes.
Results

Human, but not mouse, gelsolin prevents apoptosis
We previously demonstrated that overexpression of hGsn in Jurkat cells inhibited various forms of apoptosis (Ohtsu et al., 1997; Kamada et al., 1998) . We con®rmed these observations using human cell line, HeLa and mouse cell line, NIH3T3 and also showed that mGsn did not exert anti-apoptotic activity under the same conditions (Figure 1a, b) . In these experiments, the expression levels of hGsn and mGsn were comparable (data not shown). Since it was reported that upon cleavage with caspase-3, mGsn exerts proapoptotic activity (Kothakota et al., 1997) and hGsn is also cleaved by caspase-3 (Kothakota et al., 1997; Kamada et al., 1998) , we studied an activity of Nterminal (hGsn-N) and C-terminal (hGsn-C) fragment of hGsn to modulate apoptosis. As shown in Figure  1a , hGsn-N tended to show a very weak pro-apoptotic activity, whereas hGsn-C showed a comparable level of anti-apoptotic activity to that of hGsn, indicating that the C-terminal half of gelsolin (a.a.353 to a.a.731) is responsible for its anti-apoptotic activity. Similar results were also obtained when Cos7 cells were used (data not shown). To examine a role of endogenous hGsn in inhibiting apoptosis, we performed anti-sense experiments. Transfection of HeLa cells with an antisense plasmid signi®cantly reduced the amount of hGsn ( Figure 1c ) and reproducibly enhanced both VP16-induced and Fas-mediated apoptosis (Figure 1d , e). These ®ndings indicated that, unlike mGsn, hGsn possesses strong anti-apoptotic activity that depends on its C-terminal half.
Role of gelsolin in the mitochondria
We have recently shown that hGsn has an ability to prevent apoptotic mitochondrial changes such as cytochrome c release and loss of membrane potential (Dc) in both cells and isolated mitochondria and that a considerable fraction of overexpressed gelsolin is localized in the mitochondria (Koya et al., 2000) . To compare the intracellular localization of endogenous hGsn and overexpressed hGsn in a quantitative manner, we carried out biochemical subcellular fractionation of Jurkat cells (JP) and a derivative overexpressing hGsn (JGF). As shown in Figure 2 , endogenous hGsn mainly existed in the cytosol of JP cells with a small amount in the mitochondrial fraction, whereas a considerable fraction of overexpressed hGsn localized in the mitochondrial fraction. The presence of hGsn in the nuclear fraction was due to contaminating unbroken cells (see Materials and methods).
We also examined the direct eect of recombinant hGsn (rhGsn) and mGsn (rmGsn) on the mitochondria isolated from rat livers. As shown in Figure 3a ,b, rhGsn eciently prevented Ca 2+ -induced Dc loss and cytochrome c release in a concentration-dependent manner and to a similar extent as human Bcl-x L ( Figure 3e and data not shown), consistent with our recent ®ndings (Koya et al., 2000) . Similar results were also obtained when the mitochondria were treated with H 2 O 2 (data not shown). Consistent with the lack of anti-apoptotic activity of mGsn (Figure 1a ), recombinant mGsn (rmGsn) showed only little protective eect on the mitochondria (Figure 3c ,d). The weak protective eect of mGsn was probably due to the Ca 2+ -chelation, because Ca 2+ is essential for apoptotic mitochondrial changes (Narita et al., 1998; Shimizu and Tsujimoto, 2000) , and free Ca 2+ concentration of mitochondrial media in the presence of mGsn was lower than that of mock (mGsn, was as much as that of mGsn, the possibility was excluded that the prevention of apoptotic mitochondrial changes by hGsn was due to binding Ca 2+ . Since hGsn-C, but not hGsn-N, showed anti-apoptotic activity, we next examined the eects of these recombinant fragments on the mitochondria. As was expected, hGsn-C (but not hGsn-N) inhibited Ca 2+ -induced Dc loss to a similar extent as rhGsn ( Figure  3e ).
Interaction of gelsolin with the VDAC
We have recently shown that the VDAC is the key molecule controlling apoptotic mitochondrial changes, and is directly regulated by the Bcl-2 family of proteins (Shimizu et al., 1999 (Shimizu et al., , 2000a Shimizu and Tsujimoto, 2000) . Therefore, we examined the eect of hGsn on VDAC activity. First, we examined the physical interaction between hGsn and the VDAC. As shown in Figure 4a , b, a co-immunoprecipitation assay revealed that hGsn bound to the VDAC in hGsnoverexpressing Jurkat cells and in isolated mitochondria incubated with hGsn. In contrast, interaction between mGsn and the VDAC was not detected in NIH3T3 cells overexpressing mGsn (Figure 4c ). These results suggest that human, but not mouse, Gsn bound to the VDAC, paralleled to their anti-apoptotic activity.
We next examined the direct eect of hGsn on VDAC activity by assessing sucrose uptake into VDAC-containing liposomes, which caused swelling of the liposomes that was monitored by the decrease of light scatter using a spectrophotometer. VDAC-liposomes developed swelling in the presence of sucrose, whereas plain liposomes, heat-denatured VDAC-liposomes, and VDAC-liposomes with polyanion, a VDAC inhibitor, did not show swelling (Shimizu et al., 2000b) , indicating that sucrose uptake was mediated by VDAC. Addition of hGsn to VDAC-containing liposomes inhibited sucrose uptake to a similar extent as Bcl-x L (Figure 5a , b), indicating that hGsn was able to inhibit VDAC activity. In contrast, mGsn showed no eect on VDAC activity (Figure 5b) , consistent with its inability to prevent apoptosis and apoptotic mitochondrial changes. Furthermore, hGsn-C (but not hGsn-N) inhibited VDAC activity to a similar extent as hGsn (Figure 5b ). All these results were consistent with those obtained from the apoptosis assay (Figure 1 ) and the mitochondrial assay (Figure 3 ). Since the ability of gelsolin to regulate actin assembly is modulated by Ca 2+ , we also examined the eect of Ca 2+ on the modulation of VDAC activity by gelsolin. As shown in Figure 5c , the inhibition of VDAC activity by gelsolin was Ca
2+
-dependent: addition of Ca 2+ enhanced the inhibition of VDAC activity by gelsolin and chelation of Ca 2+ almost completely abolished the eect of hGsn (Figure 5c ). In contrast, Ca 2+ dependence was not observed when Bcl-x L was used (data not shown These results indicated that hGsn inhibited VDAC activity in a Ca 2+ -dependent manner, and probably blocked apoptotic mitochondrial changes as a consequence of VDAC inhibition.
Discussion
We previously showed that overexpression of hGsn eectively inhibits various types of apoptosis (Ohtsu et Kamada et al., 1998) . Here, we con®rmed these observations and also provided evidence for antiapoptotic activity of endogenous hGsn by anti-sense experiments, in which reduction of the endogenous expression of hGsn by an anti-sense plasmid signi®-cantly sensitized cells to VP16-induced and Fasmediated apoptosis. We also showed that hGsn directly acts on the mitochondria to prevent apoptotic mitochondrial changes, consistent with our recent observations (Koya et al., 2000) . It was reported that although most endogenous Gsn is localized in the cytoplasm, a small amount exists in the cytosolic face of the cell membranes, including the mitochondria (Hartwig et al., 1989) . This mitochondrial hGsn is probably responsible for the anti-apoptotic activity of endogenous hGsn. We also showed that overexpression of Gsn led to its accumulation in the mitochondria, consistent with the notion that hGsn prevents apoptosis by inhibiting apoptotic mitochondrial changes.
We have recently described that the VDAC is essential for apoptogenic release of cytochrome c. which is inhibited by Bcl-x L through direct bindingdependent closure of the channel (Shimizu et al., 1999 (Shimizu et al., , 2000a . Like Bcl-x L , hGsn (but not mGsn) inhibited VDAC activity in liposomes. Furthermore, analysis of hGsn, its N-terminal and C-terminal fragments and mGsn revealed that: (1) the inhibition of VDAC activity in liposomes; (2) the prevention of apoptotic changes (Dc loss or cytochrome c release) in isolated Figure 3 Inhibition of apoptotic mitochondrial changes by human, but not mouse, gelsolin. Rat liver mitochondria (1 mg) were incubated with the indicated proteins at the indicated amounts together with 40 mM Ca 2+ in 1.2 ml, and Dc was assessed using Rh123 as described in Materials and methods, over 12 min (a, c) and after 20 min (e). The cytochrome c level in supernatant fractions was also determined after incubation for 15 min (b, d). Data are representative of three independent experiments mitochondria; and (3) the prevention of apoptosis are all linked, strongly suggesting that VDAC inhibition underlies the anti-apoptotic activity of hGsn via preventing apoptotic mitochondrial changes. Given that VDAC is a component of oligo-protein channel called`permeability transition pore' that is considered to consist of proteins on both outer and inner membranes and modulates permeability of mitochondrial membranes (reviewed by Bernardi et al., 1994; and Zoratti and SzaboÂ , 1995) , it is conceivable that, like Bcl-x L , closure of VDAC by hGsn also controls, although indirectly, permeability of inner membrane. Recent ®ndings have shown that changes of the cytoskeleton are associated with alteration of mitochondrial outer membrane permeability (Rappaport et al., 1998) and VDAC binds to some cytoskeletal proteins including MAP2 (Linden and Karlsson, 1996) . Since hGsn also binds to VDAC and regulates its activity, it seems to be crucial for functional interaction between cytoskeleton and mitochondria. Since hGsn inhibits VDAC activity in a Ca 2+ -dependent manner, it seems that the structure of the active domain is modi®ed and/or the active domain is exposed for VDAC by the presence of Ca 2+ . Unlike hGsn, mGsn did not show any signi®cant activity to modulate apoptosis in HeLa and NIH3T3 cells (Figure 1 ) as well as several other mouse cell lines thus far tested (unpublished). mGsn did not show any activity to modulate mitochondrial changes (Dc and cytochrome c release) and to modulate VDAC activity. How can the functional dierence between hGsn and mGsn be explained? Within the C-terminal region of Gsn, consisting of G4, 5 and 6 domains, the G5 domain shows the lowest degree of amino acid identity between human and mouse (88% for G5 versus 100% for G4 and 98% for G6). Our preliminary studies revealed that the G5 domain of hGsn was sucient for preventing apoptotic mitochondrial changes as well as inhibiting VDAC activity (data not shown), the structural dierence of the G5 domain probably underlies the functional dierence between hGsn and mGsn. Since the a-helical structure of the BH4 domain of Bcl-x L seems to be essential for inhibition of VDAC activity (Shimizu et al., 2000b) , it is of interest to note that the G5 domain possesses a long a-helix (Burtnick et al., 1997) . The anti-apoptotic activity of mGsn (Endres et al., 1999) , if any, is probably through a dierent mechanism, such as direct inhibition of caspases through binding to phosphatidylinositol 4,5-bisphosphate (Azuma et al., 2000) .
Both hGsn and mGsn are cleaved at a single site by caspases during apoptosis (Kothakota et al., 1997; Kamada et al., 1998) . The N-terminal but not Cterminal fragment of mGsn derived from caspase cleavage was reported to show pro-apoptotic activity (Kothakota et al., 1997) . We showed that the Nterminal fragment of hGsn did show a very weak proapoptotic activity, that is overcome by strong antiapoptotic activity exerted by the C-terminal region of hGsn. Elucidation of the physiological role of caspasedependent cleavage of hGsn must await further investigation. In summary, we showed that hGsn has a unique inhibitory eect against apoptosis, apoptotic mitochondrial changes and VDAC activity.
Materials and methods
Chemicals
Anti-Gsn mAb (clone GS-2C4) which reacts with hGsn and anti-Xpress antibody which recognizes His-tag were purchased from Sigma and Invitrogen, respectively. Anti-human VDAC monoclonal antibody (31HL Ab-4), which crossreacts with rat VDAC, was obtained from Calbiochem (La Jolla, CA, USA). Anti-human VDAC polyclonal antibody was a kind gift of Drs H Terada and Y Shinohara (Tokushima University, Japan). The other chemicals used were obtained from Wako Biochemicals (Osaka, Japan).
Cell culture and induction of apoptosis
HeLa (a human cervical carcinoma cell line) and Jurkat (a lymphoblastoid T-cell line) cells were cultured in RPMI 1640 medium with 10% fetal bovine serum (FBS). NIH3T3 (a mouse ®broblast cell line) cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% FBS. JGF is derivative of Jurkat cell line overexpressing hGsn, JP is a parental cell line (Ohtsu et al., 1997) . Cell viability after treatment with anti-Fas antibody (CH-11) was assessed by nuclear morphology at the staining with 1 mM Hoechst 33342.
Transient DNA transfection and apoptosis assay DNA encoding hGsn, mGsn and hGsn mutants (hGsn-N that encodes amino acid residue 1 ± 352, hGsn-C that encodes Interaction between hGsn and the VDAC. Lysates of mitochondria (1 mg/ml) that were incubated for 5 min with hGsn (20 mg/ml) (a), and lysates from JGF cells (b) were subjected to immunoprecipitation with anti-Gsn monoclonal (ahGsn) and anti-VDAC monoclonal antibodies (aVDAC). Normal mouse IgG (NMI) was used as a control. Immune complexes were analysed by Western blotting using anti-VDAC polyclonal and anti-Gsn monoclonal antibodies. Part of lysate obtained before immnoprecipitation was also loaded (Lysate). (c) No interaction between mGsn and the VDAC. Lysates of NIH3T3 cells that were transiently transfected with an expression plasmid for mGsn were subjected to immunoprecipitation with anti-mGsn polyclonal antibody (amGsn). Normal rabbit IgG (NRI) was used as a control. Immune complexes were analysed by Western blotting using anti-VDAC polyclonal antibody amino acid residue 353 ± 731) were generated by the polymerase chain reaction using proof-reading Pfu DNA polymerase (Strategene, CA, USA) and were subcloned into the pcDNA3.1 expression vector (Invitrogen) with an Nterminal X-press tag. DNA for full-length hGsn was also subcloned into the pcDNA3.1 with a reverse orientation for an anti-sense plasmid. Using lipofectamine, cells were transfected for 24 h with the expression plasmid (0.3 mg) together with 0.1 mg of the green¯uorescence protein (GFP) expression construct (pEGFP-NI, Clontech), which was used to identify DNA-transfected cells. Then the transfected cells were treated with VP16 for 24 h. After staining with 1 mM Hoechst 33342, the extent of apoptosis was calculated as the percentage of GFP-positive cells with nuclear fragmentation relative to all GFP-positive cells. Statistical evaluation was performed by the paired t-test after analysis of variance. A Pvalue of less than 0.05 was considered statistically signi®cant.
Subcellular fractionation
JP and JGF (Ohtsu et al., 1997) were harvested. After washing twice with phosphate-buered saline (PBS), cells were resuspended at 2610 7 ml in hypotonic buer (10 mM potassium HEPES, pH 7.4, 10 mM MgCl 2 , 42 mM KCl) on ice for 10 min, and then homogenized in a Dounce homogenizer. Nuclei and unbroken cells were centrifuged at 600 g for 10 min and the pellet was used as a nuclear fraction. The supernatant was centrifuged at 10 000 g for 10 min to collect the heavy membrane fraction. This supernatant was subsequently centrifuged at 100 000 g for 90 min to yield the light membrane fraction and the cytosolic fraction. The nuclear fraction, heavy membrane fraction, and light membrane fraction were resuspended in a volume of RIPA buer equal to that of the ®nal supernatant.
Protein purification hGsn and mGsn were expressed in Escherichia coli strain BL21-DE3 (Novagen), and were puri®ed as described previously and dissolved in a buer containing 0.3 M mannitol and 10 mM HEPES/K + (pH 7.4). hGsn mutants and human Bcl-x L were expressed as GSTfusion proteins in Escherichia coli strain DH5a and were puri®ed using a glutathione-sepharose column. Then these proteins were released from GST by cleavage with thrombin. The puri®ed proteins were dissolved in a buer composed of 0.3 M mannitol and 10 mM HEPES/K + (pH 7.4). Mock control proteins were prepared using GST-proteins from an empty vector. Rat liver VDAC was puri®ed as described previously (Shimizu et al., 1999) . This VDAC showed a single band on SDS-polyacrylamide gel electrophoresis.
Measurement of mitochondrial parameters
Rat liver mitochondria (1 mg protein) were isolated as described previously (Narita et al., 1998) , that were incubated . VDAC-containing liposomes were also incubated with sucrose and hGsn in the presence of 10 mM EDTA (EDTA). Liposomal swelling was assessed as described in (a) at 258C in 1.2 ml of mitochondrial buer containing 0.3 M mannitol, 10 mM HEPES/K + (pH 7.4), 0.1% fatty acid-free bovine serum albumin, 1 mM potassium phosphate, and 4.2 mM succinate for energization with or without recombinant proteins. Dc was assessed by measuring the uptake of rhodamine 123 (Rh123) as described elsewhere (Shimizu et al., 1996) . For detection of cytochrome c release, mitochondria were spun and the pellet was resuspended in RIPA buer. The supernatant and the resuspended mitochondria were then subjected to Western blot analysis using anticytochrome c antibodies.
Immunoprecipitation and Western blot analysis
To detect interactions between hGsn and VDAC, isolated mitochondria (1 mg) were incubated with 20 mg of hGsn for 5 min. Then the mitochondria were pelleted, washed, and resuspended in lysis buer (10 mM HEPES, pH 7.4, 142.5 mM KCl, 5 mM MgCl 2 , 1 mM EGTA, and 0.5% NP40) in the presence of proteinase inhibitors (0.1 mM p-APMSF, 10 mg/ml aprotinin, 1 mg/ml chymostatin, 1 mg/ml leupeptin, 1 mg/ml antipain, and 1 mg/ml peptstatin), followed by sonication. Immunoprecipitation was performed with antiGsn and anti-VDAC monoclonal antibodies and normal mouse IgG. Coimmunoprecipitation of Gsn and VDAC was detected by Western blotting using an anti-Gsn monoclonal antibody and anti-VDAC polyclonal antibody, respectively. For coimmunoprecipitation experiments with Jurkat cells (JGF) and NIH3T3 transfected with an expression plasmid for mGsn were performed using Dimethyl 3, 3'-dithiobispropionimidate-2HCl (DTBP) as a protein cross-linker as described previously (Narita et al., 1998) . Cells were washed twice with PBS and incubated with 2 mM DTBP in PBS for 30 min. After washing three times with PBS, cells were lysed, sonicated, and subjected to immunoprecipitation as described above. Coimmunoprecipitation of mGsn was detected by Western blotting using an anti-mGsn polyclonal antibody (Fujita et al., 1995) .
Reconstitution of VDAC in liposomes
Puri®ed VDAC was reconstituted in small unilamelar vesicles by the sonic freeze-thaw procedure described previously (Shimizu et al., 1999) . A sucrose import experiment was performed by assessing liposomal swelling as described previously Shimizu et al., 2000a,b) . Brie¯y, VDAC-liposomes (10 ml) produced at pH 5.2 were incubated in 1 ml of liposome medium containing 30 mM sodium sulphite and 20 mM Tricine-NaOH (pH 5.2) together with hGsn, mGsn, hGsn mutants or Bcl-x L for 3 min at 258C (an acidic pH was required for ecient incorporation of Bcl-x L (Shimizu et al., 1999) ). Then sucrose was added to a ®nal concentration of 50 mM, and liposomal swelling was assessed by monitoring the decrease of light scatter at a wavelength of 520 nm using a spectrophotometer (F-4500; Hitachi).
Abbreviations VDAC, voltage-dependent anion channel; Gsn, gelsolin; GST, glutatione S-transferase: Dc, mitochondrial membrane potential; AIF, apoptosis-inducing factor
